Literature DB >> 11268387

Variability of interactions between neuroendocrine and immunological functions in physiological aging and dementia of the Alzheimer's type.

E Ferrari1, M Fioravanti, F Magri, S B Solerte.   

Abstract

A link between neuroendocrine and immunological changes has been suggested in the pathophysiology of dementia of the Alzheimer's type (DAT). Healthy young and old subjects and patients with DAT were recruited to evaluate the chrononeuroendocrine organization of cortisol, GH, and melatonin (MLT) secretions. The study was carried out together with the evaluation of natural killer (NK) cell function: cytotoxic activity (NKCC) and TNF-alpha and IFN-gamma release after exposure to IL-2 (100 U/mL). Moreover, a cerebral morphometric analysis of hippocampus and temporal lobe (MRI) was performed. The activation of hypothalamo-pituitary-adrenal (HPA) axis and the decrease of GH, and MLT nocturnal peaks were associated with normal NKCC and TNF-alpha/IFN-gamma in healthy elderly subjects, whereas in DAT patients the same neuroendocrine changes occurred together with abnormal NKCC (spontaneous and IL-2/IFN-beta-modulated) and with alterations of TNF-alpha/INF-gamma generation from NK. Moreover significant correlations among the increase of NKCC and TNF-alpha and the decrease of cognitive function were found in the DAT group. These correlations were associated with the impairment of nocturnal GH and MLT levels and with the relatively higher serum cortisol concentrations. Moreover, the impairment of cortisol suppression after dexamethasone (1 mg orally at 23:00) was significantly correlated with the increase of spontaneous release of TNF-alpha and with IL-2-modulated NKCC. Finally the imunoneuroendocrine alterations found in DAT were associated with the reduction of cerebral volume in hippocampus and temporal lobes. Taken together these data indicate that the immunoneuroendocrine balance is maintained in physiological aging, whereas NK immune dysregulation in DAT could contribute to altering the neuroendocrine functions and to extend the progression of neurodegeneration and dementia.

Entities:  

Mesh:

Year:  2000        PMID: 11268387     DOI: 10.1111/j.1749-6632.2000.tb05424.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

3.  Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.

Authors:  Valeria Mondelli; Carmine M Pariante; Serena Navari; Monica Aas; Alessandro D'Albenzio; Marta Di Forti; Rowena Handley; Nilay Hepgul; Tiago Reis Marques; Heather Taylor; Andrew S Papadopoulos; Katherine J Aitchison; Robin M Murray; Paola Dazzan
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

Review 4.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 5.  Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?

Authors:  Sarah B Mathews; Steven E Arnold; C Neill Epperson
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

6.  Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

Review 7.  Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.

Authors:  Rüdiger Hardeland
Journal:  ScientificWorldJournal       Date:  2012-05-02

8.  Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?

Authors:  Donald J Lehmann; Martin C N M Barnardo; Susan Fuggle; Isabel Quiroga; Andrew Sutherland; Donald R Warden; Lin Barnetson; Roger Horton; Stephan Beck; A David Smith
Journal:  J Neuroinflammation       Date:  2006-12-18       Impact factor: 8.322

9.  Individual Patient Research (IPR) Outcomes with Alzheimer's Disease: The Psycho-neuro-immune Viewpoint.

Authors:  Francesco Chiappelli; Allen Khakshooy
Journal:  Bioinformation       Date:  2016-08-15

10.  Identification of a benzamide derivative that inhibits stress-induced adrenal corticosteroid synthesis.

Authors:  Jing Xu; Laurent Lecanu; Matthew Tan; Janet Greeson; Vassilios Papadopoulos
Journal:  Molecules       Date:  2009-09-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.